Title:
|
Resolution retroactively approving an agreement between McKesson Plasma and Biologics LLC and the Department of Public Health for the purchase of pharmaceutical products, biologics and specialty drugs for a total amount not to exceed $295,934,790 for a term of five years, from February 1, 2020, through January 31, 2024.
|